Literature DB >> 527881

Bile acid studies in patients with Crohn's colitis.

P Rutgeerts, Y Ghoos, G Vantrappen.   

Abstract

Bile acid studies were performed in patients with Crohn's disease, radiologically confined to the colon. The bile acid pool size of 10 patients with isolated Crohn's colitis was significantly lower than that of 10 normal control subjects (P less than 0.001) and of 10 ulcerative colitis patients (P less than 0.005). Measurements of 14C-excretion in breath and in 24 hours stool collections after the administration of 5 muCi 14C-glycocholate showed a normal 14C-excretion in breath and usually a markedly increased loss of 14C in the stool (greater than 7% of the dose). The simultaneous administration of 5 muCi 3H-polyethylene glycol MW 4000 (3H-PEG) as a marker indicated that the 14C/3H ratio in the patients with Crohn's colitis was significantly greater than in a control series of patients with diarrhoea not due to bile acid malabsorption. Studies on the composition of duodenal bile showed a significantly decreased concentration of deoxycholic acid in duodenal bile. These observations suggest bile acid malabsorption in patients with Crohn's disease apparently confined to the colon.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527881      PMCID: PMC1412836          DOI: 10.1136/gut.20.12.1072

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

Review 1.  Disturbances of bile acid metabolism in intestinal disease.

Authors:  K W Heaton
Journal:  Clin Gastroenterol       Date:  1977-01

2.  Measurement and validation of human bile salt pool size and synthesis.

Authors:  E W Pomare; T S Low-Beer
Journal:  Clin Chim Acta       Date:  1974-12-17       Impact factor: 3.786

3.  Breath test for altered bile-acid metabolism.

Authors:  H Fromm; A F Hofmann
Journal:  Lancet       Date:  1971-09-18       Impact factor: 79.321

4.  Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients.

Authors:  H Fromm; P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-06       Impact factor: 22.682

5.  Disappearance of deoxycholic acid after ileal resection.

Authors:  F Kern
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

6.  Clean collection and manipulation of stools.

Authors:  Y Ghoos; G Vantrappen
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

7.  Bile acid metabolism and vitamin B12 absorption in ulcerative colitis.

Authors:  K Lenz
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

8.  Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

9.  Bile acid studies in uncomplicated Crohn's disease.

Authors:  G Vantrappen; Y Ghoos; P Rutgeerts; J Janssens
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

10.  14C-Glycocholate test in Crohn's disease--its value in assessment and treatment.

Authors:  J H Scarpello; G E Sladen
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

View more
  9 in total

Review 1.  Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.

Authors:  Thomas Siegmund Postler; Sankar Ghosh
Journal:  Cell Metab       Date:  2017-06-15       Impact factor: 27.287

2.  Biliary lipid composition in patients with nonoperated Crohn's disease.

Authors:  P Rutgeerts; Y Ghoos; G Vantrappen; J Fevery
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

3.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Authors:  Carsten Gnewuch; Gerhard Liebisch; Thomas Langmann; Benjamin Dieplinger; Thomas Mueller; Meinhard Haltmayer; Hans Dieplinger; Alexandra Zahn; Wolfgang Stremmel; Gerhard Rogler; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 4.  Commensal bacteria at the interface of host metabolism and the immune system.

Authors:  Jonathan R Brestoff; David Artis
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

5.  Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn's disease on elemental diet.

Authors:  T Koga; T Nishida; H Miwa; M Yamamoto; K Kaku; T Yao; M Okumura
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

6.  Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid.

Authors:  T Nishida; H Miwa; M Yamamoto; T Koga; T Yao
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

7.  Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

Authors:  Rian M Nijmeijer; Raffaella M Gadaleta; Saskia W C van Mil; Adriaan A van Bodegraven; J Bart A Crusius; Gerard Dijkstra; Daan W Hommes; Dirk J de Jong; Pieter C F Stokkers; Hein W Verspaget; Rinse K Weersma; C Janneke van der Woude; Janneke M Stapelbroek; Marguerite E I Schipper; Cisca Wijmenga; Karel J van Erpecum; Bas Oldenburg
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

8.  Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

Authors:  Fiona D M van Schaik; Raffaella M Gadaleta; Frank G Schaap; Saskia W C van Mil; Peter D Siersema; Bas Oldenburg; Karel J van Erpecum
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

Review 9.  Bile Acids, Their Receptors, and the Gut Microbiota.

Authors:  James C Poland; C Robb Flynn
Journal:  Physiology (Bethesda)       Date:  2021-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.